- Home
- SST vs POM Comparison
SST vs POM Comparison
Compare SST & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | POM |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | China |
| Employees | 300 | N/A |
| Industry | Diversified Commercial Services | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 26.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SST | POM |
|---|---|---|
| Price | $2.72 | $0.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 8.2K | ★ 386.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $0.19 |
| 52 Week High | $11.30 | $6.43 |
Technical Indicators
Market Signals| Indicator | SST | POM |
|---|---|---|
| Relative Strength Index (RSI) | 29.29 | 48.57 |
| Support Level | $0.34 | $0.28 |
| Resistance Level | $4.71 | $0.41 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 11.70 | 43.28 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.